The
increasing prevalence of drug-resistant bacterial strains is
causing illness and death in an unprecedented number of people around
the globe. Currently implemented small-molecule antibiotics are both
increasingly less efficacious and perpetuating the evolution of resistance.
Here, we propose a new treatment for drug-resistant bacterial infection
in the form of indium phosphide quantum dots (InP QDs), semiconductor
nanoparticles that are activated by light to produce superoxide. We
show that the superoxide generated by InP QDs is able to effectively
kill drug-resistant bacteria in vivo to reduce subcutaneous
abscess infection in mice without being toxic to the animal. Our InP
QDs are activated by near-infrared wavelengths with high transmission
through skin and tissues and are composed of biocompatible materials.
Body weight and organ tissue histology show that the QDs are nontoxic
at a macroscale. Inflammation and oxidative stress markers in serum
demonstrate that the InP QD treatment did not result in measurable
effects on mouse health at concentrations that reduce drug-resistant
bacterial viability in subcutaneous abscesses. The InP QD treatment
decreased bacterial viability by over 3 orders of magnitude in subcutaneous
abscesses formed in mice. These InP QDs thus provide a promising alternative
to traditional small-molecule antibiotics, with the potential to be
applied to a wide variety of infection types, including wound, respiratory,
and urinary tract infections.